These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7757107)

  • 21. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP
    Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome: a comparative study with anticardiolipin antibodies.
    Sanmarco M; Soler C; Christides C; Raoult D; Weiller PJ; Gerolami V; Bernard D
    J Lab Clin Med; 1997 May; 129(5):499-506. PubMed ID: 9142046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospholipid-dependent anti-beta 2-glycoprotein I (beta 2-GPI) antibodies and antiphospholipid syndrome.
    Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
    Intern Med; 1996 Feb; 35(2):105-10. PubMed ID: 8680096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
    Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
    Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies to oxLig-1/beta2-glycoprotein I in patients with systemic lupus erythematosus and antiphospholipid syndrome.
    Lopez D; Garcia-Valladares I; Palafox-Sanchez CA; De La Torre IG; Kobayashi K; Matsuura E; Lopez LR
    Am J Clin Pathol; 2004 Mar; 121(3):426-36. PubMed ID: 15023048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations.
    Tektonidou MG; Petrovas CA; Ioannidis JP; Vlachoyiannopoulos PG; Moutsopoulos HM
    Eur J Clin Invest; 2000 Jul; 30(7):646-52. PubMed ID: 10886305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus.
    Cucurull E; Gharavi AE; Diri E; Mendez E; Kapoor D; Espinoza LR
    Am J Med Sci; 1999 Jul; 318(1):55-60. PubMed ID: 10408762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DRB1 alleles and beta 2 glycoprotein I-dependent anticardiolipin antibodies in Japanese patients with systemic lupus erythematosus.
    Hashimoto H; Yamanaka K; Tokano Y; Iida N; Takasaki Y; Kabasawa K; Nishimura Y
    Clin Exp Rheumatol; 1998; 16(4):423-7. PubMed ID: 9706422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
    Borodin AG; Baranov NG; Nasonov EL
    Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.
    Ali HY; Abdullah ZA
    J Immunotoxicol; 2008 Apr; 5(2):173-7. PubMed ID: 18569388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Igarashi A; Soma Y; Tamaki K; Takehara K
    Clin Exp Immunol; 1996 Sep; 105(3):475-9. PubMed ID: 8809137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.